Search Results - "Natama, Magloire H"
-
1
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study
Published in The Lancet infectious diseases (01-05-2024)“…The R21/Matrix-M vaccine has demonstrated high efficacy against Plasmodium falciparum clinical malaria in children in sub-Saharan Africa. Using trial data, we…”
Get full text
Journal Article -
2
Wastewater from healthcare centers in Burkina Faso is a source of ESBL, AmpC-β-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae
Published in BMC microbiology (17-11-2023)“…Abstract Background Extended-spectrum β-lactamase (ESBL), plasmid-mediated AmpC-β-lactamase and carbapenemase-producing Escherichia coli and Klebsiella…”
Get full text
Journal Article -
3
Phenotypic Detection of Carbapenemase and AmpC-β-Lactamase Production among Extended Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella spp. Isolated from Clinical Specimens
Published in Antibiotics (Basel) (01-01-2024)“…: Data on antimicrobial resistance (AMR) are sparse across numerous African countries, as microbiological analyses are not routinely conducted and surveillance…”
Get full text
Journal Article -
4
Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patients
Published in EBioMedicine (01-09-2022)“…Artemisinins (ART) are the key component of the frontline antimalarial treatment, but their impact on Plasmodium falciparum sexual conversion rates in natural…”
Get full text
Journal Article -
5
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
Published in The Lancet (British edition) (15-05-2021)“…Stalled progress in controlling Plasmodium falciparum malaria highlights the need for an effective and deployable vaccine. RTS,S/AS01, the most effective…”
Get full text
Journal Article -
6
Wastewater from healthcare centers in Burkina Faso is a source of ESBL, AmpC-[beta]-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae
Published in BMC microbiology (17-11-2023)“…Extended-spectrum [beta]-lactamase (ESBL), plasmid-mediated AmpC-[beta]-lactamase and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae have…”
Get full text
Journal Article -
7
Phenotypic Detection of Carbapenemase and AmpC-β-Lactamase Production among Extended Spectrum β-Lactamase -Producing IEscherichia coli/I and IKlebsiella/I spp. Isolated from Clinical Specimens
Published in Antibiotics (Basel) (01-12-2023)“…Introduction: Data on antimicrobial resistance (AMR) are sparse across numerous African countries, as microbiological analyses are not routinely conducted and…”
Get full text
Journal Article